CSPC Innovation Pharmaceutical Co., Ltd. (SHE: 300765)
China flag China · Delayed Price · Currency is CNY
27.11
-0.47 (-1.70%)
Nov 13, 2024, 3:04 PM CST

CSPC Innovation Pharmaceutical Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 2018 - 2014
Cash & Equivalents
1,2943,4222,1961,2441,139475.14
Upgrade
Trading Asset Securities
---413.59321.94960.09
Upgrade
Cash & Short-Term Investments
1,2943,4222,1961,6581,4611,435
Upgrade
Cash Growth
-59.15%55.86%32.43%13.51%1.77%817.71%
Upgrade
Accounts Receivable
524.56545.03716.75508.94303.96349.77
Upgrade
Other Receivables
54.331.421.561.371.81.47
Upgrade
Receivables
578.89546.45718.31510.31305.76351.24
Upgrade
Inventory
321.24223.68238.13262111124.23
Upgrade
Other Current Assets
160.427.5738.4756.9235.626.32
Upgrade
Total Current Assets
2,3544,2203,1912,4871,9131,937
Upgrade
Property, Plant & Equipment
2,4721,0591,055926.42727.49678.17
Upgrade
Long-Term Investments
264.22267.07253.49243.19235.87156.29
Upgrade
Goodwill
----3.473.47
Upgrade
Other Intangible Assets
226.8148.0350.4252.8155.2157.57
Upgrade
Long-Term Deferred Tax Assets
17.5917.3618.8812.510.3912.88
Upgrade
Other Long-Term Assets
383.4120.6115.919.069.436.99
Upgrade
Total Assets
5,7185,6324,5843,7412,9552,852
Upgrade
Accounts Payable
409.95173.68178.75129.1764.1692.7
Upgrade
Accrued Expenses
25.7163.4266.2454.5725.118.63
Upgrade
Current Portion of Long-Term Debt
--0.22---
Upgrade
Current Portion of Leases
0.830.81-0.84--
Upgrade
Current Income Taxes Payable
19.8728.3634.7714.9510.2614
Upgrade
Current Unearned Revenue
22.9519.868.2630.3725.27-
Upgrade
Other Current Liabilities
395.77224.77234.52178.75109.46275.42
Upgrade
Total Current Liabilities
875.08510.84582.77408.64234.24400.76
Upgrade
Long-Term Debt
--19.8---
Upgrade
Long-Term Leases
0.210.84----
Upgrade
Long-Term Unearned Revenue
94.433.2637.2134.2733.3135.66
Upgrade
Long-Term Deferred Tax Liabilities
0.50.020.060.670.450.65
Upgrade
Total Liabilities
970.19544.96639.84443.58268437.06
Upgrade
Common Stock
1,4051,171618.93546420200
Upgrade
Additional Paid-In Capital
975.51,0751,1381,211882.281,102
Upgrade
Retained Earnings
1,7532,8352,1771,5331,3761,104
Upgrade
Treasury Stock
-321.03-4.25----
Upgrade
Comprehensive Income & Other
1.481.980.72-1.2-0.10.03
Upgrade
Total Common Equity
3,8135,0793,9363,2892,6782,406
Upgrade
Minority Interest
934.818.358.598.268.798.91
Upgrade
Shareholders' Equity
4,7485,0873,9443,2982,6872,415
Upgrade
Total Liabilities & Equity
5,7185,6324,5843,7412,9552,852
Upgrade
Total Debt
1.051.6520.020.84--
Upgrade
Net Cash (Debt)
1,2933,4212,1761,6571,4611,435
Upgrade
Net Cash Growth
-59.16%57.22%31.29%13.45%1.77%1572.70%
Upgrade
Net Cash Per Share
0.932.461.631.241.241.30
Upgrade
Filing Date Shares Outstanding
1,3931,4051,3371,1791,1791,179
Upgrade
Total Common Shares Outstanding
1,3931,4051,3371,1791,1791,179
Upgrade
Working Capital
1,4793,7092,6082,0791,6791,536
Upgrade
Book Value Per Share
2.743.622.942.792.272.04
Upgrade
Tangible Book Value
3,5875,0313,8853,2372,6192,345
Upgrade
Tangible Book Value Per Share
2.583.582.912.742.221.99
Upgrade
Buildings
-615.21609.24430.75397.71382.16
Upgrade
Machinery
-1,009925.79701.65475.66447.03
Upgrade
Construction In Progress
-62.1570.74294.97154.83108.13
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.